NYKD — Nykode Therapeutics ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Nykode Therapeutics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	208	228	206	162	115
Net Total Accounts Receivable
Net Total Receivables	20.1	26.2	4.33	1.07	0.908
Prepaid Expenses
Total Other Current Assets
Total Current Assets	229	256	212	166	117
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.408	9.16	9.53	10.5	7.74
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	230	266	221	208	153
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.2	31.4	39	20.6	9.1
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	51.2	71.5	64.5	36.9	17.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	179	194	157	171	136
Total Liabilities & Shareholders' Equity	230	266	221	208	153
Total Common Shares Outstanding